Fiscal 1990 budget agreement
Budget bill unanimously adopted by a House/Senate conference committee on May 11 includes $ 100 mil. in "unspecified savings" in health program. Staffers say the line item, adopted from the Senate version, was inspired by the Bush Administration's FDA user fee proposal. However, they note, the savings are "assumed" but not "forced" upon the authorization or appropriations committees. Leaders of both the Senate Labor & Human Resources Committee and the House Energy & Commerce Committee -- including Sens. Kennedy (D-Mass.) and Hatch (R-Utah), and Rep. Waxman (D-Calif.) -- oppose FDA user fees. The budget plan must be approved by the full House and Senate.
You may also be interested in...
Centaur-CytoTools introduces novel topical treatment for diabetic foot ulcers in India, for which they see limited direct competition and hope to change the way the difficult-to-treat diabetes complication is managed. Phase III studies are ongoing in Europe.
The head of the US Food and Drug Administration praised the life-saving work of device center staff in response to the coronavirus pandemic.
Decision on Regeneron’s Ebola virus therapy, which uses a similar monoclonal antibody cocktail approach as the company’s COVID-19 therapy candidate, stands out among the 10 user fee goal dates in the coming month.